biocon biologics
-
Biocon Biologics partners with Sandoz
Biocon Biologics will have exclusive rights to promote, sell and distribute Adalimumab BS for subcutaneous injection [FKB] in Japan Biocon…
Read More » -
Kedar Upadhye appointed as CFO of Biocon Biologics
Current CFO MB Chinappa to take on a Strategic Finance role at Biocon Group Biocon Biologics, a subsidiary of Biocon…
Read More » -
Biocon Biologics expands footprint in emerging markets
Takes over the commercialization of biosimilars susiness from Viatris in 70+ countries Biocon Biologics has completed the integration of the acquired…
Read More » -
Dr Devi Shetty, Kiran Mazumdar Shaw inaugurate 10-bed BMT unit at Mazumdar Shaw Medical Centre, Narayana Health City
The capacity has been strengthened its capacity to 34 beds Dr Devi Shetty, CEO, Narayana Health and Kiran Mazumdar Shaw,…
Read More » -
Biocon Biologics completes acquisition of Viatris’ global biosimilars biz
Viatris to provide commercial and other services for up to 2 years to ensure a seamless transition and continued service…
Read More » -
Biocon Biologics, Viatris launch Abevmy in Canada
The two formats of Abevmy are available in 100 mg/4 mL single-use vial and 400 mg/16 mL single-use vial Biocon…
Read More » -
Biocon Biologics’ Insugen bags three-year contract in Malaysia
Biocon Biologics’ Insugen formulations will be available to patients at all Ministry of Health hospitals, district health offices and health…
Read More » -
Kiran Mazumdar-Shaw elected as Fellow of Royal Society of Edinburgh
She will be joining RSE’s current Fellowship of around 1,700 Fellows Kiran Mazumdar-Shaw, Executive Chairperson of Biocon and Biocon Biologics,…
Read More » -
Biocon Biologics to acquire Viatris’ biosimilars assets
The acquisition will be for up to $3.335 billion in stock and cash Biocon Biologics, a subsidiary of Biocon has…
Read More »